Clinical Trial Update: A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 safety extension trial of trastuzumab emtansine in patients previously treated with T-DM1, alone or with other ant…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Kadcyla (ado-trastuzumab emtansine)

Snippet

Sponsor: Genentech, Inc. | Conditions: Neoplasm Metastasis | Phase 2 | Status: ACTIVE_NOT_RECRUITING